Tag: Nirmala Sitharaman

Finance Minister Nirmala Sitharaman announces a five-year push to boost biologics research, manufacturing and innovation

Industry leaders share their expectations form the union budget 2026 all set to be presented on 1st February

Exemptions for life-saving drugs and sharp cuts on diagnostics, Medtech, and insurance reshape India’s healthcare affordability landscape.

The Cover Story analyses the potential impact of significant uncertainty due to the proposed reciprocal tariffs with insights from Vishal Dhikale, Associate Vice President, Avalon Consulting. Read interview of Puneeth Kumar KT, Business Director for Planetary Health Biosolutions, Novonesis South Asia and Expert Insights by Mahesh Ramanujam, President & CEO, Global Network for Zero; and Dr Vidhi Bhanushali, CEO and Co-founder, scanO.

The allocations are significant but not on expected lines for healthcare and biotechnology industry

Industry leaders expect incentives for digital health adoption and interoperability between private and public healthcare systems

The leading stakeholders of the Indian medical devices industry share their expectations from the union budget 2025 slated for 1st February

The decision was taken in the 54th GST Council meeting chaired by the Union Finance Minister Nirmala Sitharaman held in New Delhi on October 09, 2024

New Delhi: Agriculture industry stakeholders have hailed the announcements made in the Budget 2024 to boost the sector. Apart from lauding the huge allocation,...

Read the detailed reactions from the stakeholders across various segments including medical technology, hospitals and diagnostics